Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-04-06

Clinical Trial Update: TruSkin®: Study for the Treatment of Chronic Diabetic Foot Ulcers [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating TruSkin for chronic diabetic foot ulcers has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TruSkin

Snippet

Sponsor: Osiris Therapeutics | Conditions: Diabetic Foot Ulcers | Phase 4 | Status: TERMINATED